Clinical Trials Browser

Active not recruiting × 16-fluoroestradiol × Breast × Clear all

NCT02398773 2026-03-18

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

Phase 2 Active not recruiting

HER2/Neu Negative

NCT04692103 2026-01-22

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Phase 2 Active not recruiting

2 enrolled 8 charts

Breast Neoplasms